Literature DB >> 7583561

Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma.

T Murakami1, S Michelagnoli, R Longhi, G Gianfranceschi, F Pazzucconi, L Calabresi, C R Sirtori, G Franceschini.   

Abstract

Lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) are responsible for the esterification of cell-derived cholesterol and for the transfer of newly synthesized cholesteryl esters (CE) from HDL to apoB-containing lipoproteins in human plasma. LCAT and CETP are also crucial factors in HDL remodeling, a process by which HDL particles with a high capacity for cell cholesterol uptake are generated in plasma. In the present study, cholesterol esterification and transfer were evaluated in 60 patients with isolated hypercholesterolemia (HC, n = 20) and isolated (HTG, n = 20) or mixed hypertriglyceridemia (MHTG, n = 20) and in 20 normolipidemic healthy individuals (NL). Cholesterol esterification rate (CER) and net CE transfer rate (CETR) were measured in whole plasma. LCAT and CETP concentrations were determined by specific immunoassays. HDL remodeling was analyzed by monitoring changes in HDL particle size distribution during incubation of whole plasma at 37 degrees C. Mean CER and CETR were 48% and 73% higher, respectively, in hypertriglyceridemic (HTG + MHTG) versus normotriglyceridemic individuals. HDL remodeling was also significantly accelerated in plasma from hypertriglyceridemic patients. Strong positive correlations were found in the total sample between plasma and VLDL triglyceride levels and CER (r = .722 and r = .642, respectively), CETR (r = .510 and r = .491, respectively), and HDL remodeling (r = .625 and r = .620, respectively). No differences in plasma LCAT and CETP concentrations were found among the various groups except for a tendency toward higher CETP levels in hypercholesterolemic patients (+51% in MHTG and +20% in HC) versus control subjects (NL). By stepwise regression analysis, VLDL triglyceride level was the sole significant predictor of CER and CETR and contributed significantly together with baseline HDL particle distribution to HDL remodeling. These results indicate that plasma triglyceride level is a major factor in the regulation of cholesterol esterification/transfer and HDL remodeling in human plasma, whereas LCAT/CETP concentrations play a minor role in the modulation of reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583561     DOI: 10.1161/01.atv.15.11.1819

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  34 in total

1.  Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.

Authors:  Richard E Morton; Diane J Greene
Journal:  J Lipid Res       Date:  2011-09-21       Impact factor: 5.922

Review 2.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

3.  Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux.

Authors:  David G McLaren; Stephen F Previs; Robert D Phair; Steven J Stout; Dan Xie; Ying Chen; Gino M Salituro; Suoyu S Xu; Jose M Castro-Perez; Gregory J Opiteck; Karen O Akinsanya; Michele A Cleary; Hayes M Dansky; Douglas G Johns; Thomas P Roddy
Journal:  J Lipid Res       Date:  2015-12-09       Impact factor: 5.922

4.  Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

Authors:  B Lamarche; K D Uffelman; A Carpentier; J S Cohn; G Steiner; P H Barrett; G F Lewis
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

5.  Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.

Authors:  Shigemasa Tani; Atsuhiko Takahashi; Ken Nagao; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2015-04-19       Impact factor: 2.037

6.  Plasma cholesteryl ester transfer protein and lipoprotein levels during treatment of growth hormone-deficient adult humans.

Authors:  A J Carrilho; M B Cunha-Neto; V S Nunes; A M Lottenberg; W L Medina; E R Nakandakare; N R Musolino; M D Bronstein; E C Quintão
Journal:  Lipids       Date:  2001-06       Impact factor: 1.880

7.  ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.

Authors:  Richard E Morton; Yan Liu; Lahoucine Izem
Journal:  J Lipid Res       Date:  2019-09-11       Impact factor: 5.922

8.  Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro.

Authors:  Laura K Potter; Dennis L Sprecher; Max C Walker; Frank L Tobin
Journal:  J Lipid Res       Date:  2009-03-11       Impact factor: 5.922

9.  Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex.

Authors:  Yubin He; Diane J Greene; Michael Kinter; Richard E Morton
Journal:  J Lipid Res       Date:  2008-03-27       Impact factor: 5.922

10.  Early postoperative changes of HDL subfraction profile and HDL-associated enzymes after laparoscopic sleeve gastrectomy.

Authors:  Serdar Doğan; Ibrahim Aslan; Ramazan Eryılmaz; Cemal Ozben Ensari; Tuna Bilecik; Mutay Aslan
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.